Notice of Effectiveness (effect)
2023年6月14日 - 7:02PM
Edgar (US Regulatory)
|
UNITED STATES
|
|---|
|
SECURITIES AND EXCHANGE COMMISSION
|
|---|
|
Washington, D.C. 20549
|
|---|
NOTICE OF EFFECTIVENESS |
|---|
|
| Effective Date: | June 13,
2023 |
|---|
| Accession Number: | 0001213900-23-044792 |
|---|
| Submission Type: | POS AM |
|---|
| CIK: | 0001415397 |
|---|
| Company Name: | Raphael Pharmaceutical Inc. |
|---|
| File Number: | 333-265878 |
|---|
Raphael Pharmaceutical (QB) (USOTC:RAPH)
過去 株価チャート
から 6 2024 まで 7 2024
Raphael Pharmaceutical (QB) (USOTC:RAPH)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Raphael Pharmaceutical Inc (QB) (その他OTC): 0 recent articles
その他のRaphael Pharmaceutical Inc.ニュース記事